Many patients suffer from epilepsy that cannot be controlled by current medications. Surgical removal of epileptogenic brain regions is effective in only about half of cases, and not all patients are ...
CHICAGO — A one-time dose of a novel cell therapy appeared safe and produced months-long seizure control in patients with bilateral drug-resistant mesial temporal lobe epilepsy (MTLE), according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results